Monsanto enters pharmaceutical business, acquires key ‘gene silencing’ technology for use in humans

by: Ethan A. Huff




Monsanto wants to turn food crops into gene-altering ‘drugs’




Modifying food crops with RNAi is unsafe, unpredictable


A paper compiled by Greenpeace about the same strains of RNAi-modified wheat explain that RNAi modifications in general “are prone to unexpected and unpredictable effects that have not been considered in the risk assessments done by the Office of the Gene Technology Regulator.” The paper goes on to explain that releasing RNAi-modified crops “poses severe, and potentially irreversible, risks to the environment and human and animal health.”

Many foods contain natural gene regulators, and modifying them could change the entire human genome


Synthetically altering these functions in the form of RNAi-modified GM crops, in other words, could result in disastrous consequences as the entire human genome is thrown off balance. As Ari Levaux from The Atlantic puts it, the discovery of food’s natural gene-altering capacities illustrates how GM foods, and particularly those that have been RNAi-modified, “could influence human health in previously unanticipated ways.”


Learn more:


One response to “Monsanto enters pharmaceutical business, acquires key ‘gene silencing’ technology for use in humans

  1. Reblogged this on MottledThrush and commented:
    OMG! WE the people need to start lobbying our governments to put a halt to this madness.

Leave a Reply


You are commenting using your account. Log Out / Change )

Twitter picture


Facebook photo


Google+ photo


Connecting to %s